Discover how Trop-2 is revolutionizing breast cancer treatment through targeted antibody-drug conjugates and immunotherapy combinations.
Exploring the biological connections between type 2 diabetes and breast cancer, including shared mechanisms, research findings, and clinical implications.
A landmark study challenges when to use powerful but costly drugs for advanced breast cancer treatment, showing academic research's power and challenges.
Exploring how Oncotype DX test results interact with CHEK2, ATM, and PALB2 germline pathogenic variants in breast cancer treatment decisions.
Discover how miR-495, a tiny molecule, regulates estrogen and progesterone receptors in breast cancer, offering new diagnostic and therapeutic possibilities.
Explore how Oncotype DX genomic testing is transforming breast cancer treatment decisions across diverse populations in North Carolina through precision medicine.
Exploring how Organic Anion Transporting Polypeptides (OATPs) serve as molecular gateways for estrogen precursors in breast cancer cells, offering new targets for precise diagnosis and treatment.
Exploring the scientific evidence on lipofilling safety for BRCA mutation carriers undergoing breast reconstruction after risk-reducing mastectomy.
Discover how IGF-1R protein expression in normal breast tissue can predict breast cancer risk years before development. Explore the groundbreaking research and its implications.
A groundbreaking study reveals how flaxseed derivatives might reshape breast tissue at the cellular level, offering new hope for cancer prevention.